The CEPHEUS trial highlights DVRd's greater treatment durability and tolerability, with more patients remaining on treatment through cycle 36 compared to VRd. Both DVRd and VRd regimens led to ...

In the PERSEUS study (Abstract #7501), transplant-eligible patients who received DARZALEX FASPRO with bortezomib, lenalidomide, and dexamethasone (D-VRd), followed by investigational maintenance ...

The FDA has approved Sarclisa (isatuximab) as a first-line therapy for blood cancer multiple myeloma as a combination regimen alongside bortezomib, lenalidomide, and dexamethasone (VRd), for ...

(Bloomberg) -- Home Depot Inc. maintained its guidance for the fiscal year as US sales ticked up, a sign that consumer spending has held up despite economic turbulence. While the world’s largest ...

The addition of subcutaneous daratumumab (Darzalex) to bortezomib (Velcade), lenalidomide (Revlimid), and dexamethasone (D-VRd) as induction and consolidation therapy ...

Taewoong Choi, MD: In the NCCN guidelines, Dara-Rd [daratumumab (Darzalex), lenalidomide (Revlimid), and dexamethasone] is one of the preferred regimens, and also now included in the recommendations ...

VRD Pharmaceuticals AND Surgicals Private Limited is an Indian Non-Government Company. It's a private company and is classified as'company limited by shares'. Company's authorized capital stands at Rs ...

Prevent this user from interacting with your repositories and sending you notifications. Learn more about blocking users.